Related Experiment Videos
Status of dideoxyinosine in clinical trials
1Department of Pharmacy, Warren G. Magnuson Clinical Center, Bethesda, MD 20892.
American Journal of Hospital Pharmacy
|June 1, 1991
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for human leukocyte antigen B (HLA-B) genotype and allopurinol dosing: 2015 update.
Clinical pharmacology and therapeutics·2015
A continuous-improvement approach for reducing the number of chemotherapy-related medication errors.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2001
A review of paclitaxel (Taxol) administration, stability, and compatibility issues.
Clinical journal of oncology nursing·1999
Standardizing the expression and nomenclature of cancer treatment regimens. American Society of Health-System Pharmacist (ASHP), American Medical Association (AMA), American Nurses Association (ANA).
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·1998
Clinical overview of the taxanes.
Pharmacotherapy·1997
Phase I study of paclitaxel in combination with cyclophosphamide and granulocyte colony-stimulating factor in metastatic breast cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1996
Clozapine therapy for Parkinson's disease and other movement disorders.
American journal of hospital pharmacy·1994
Venlafaxine: a heterocyclic antidepressant.
American journal of hospital pharmacy·1994
Multi-Omics Genome-Wide to Explore the Formation and Development Targets for Intracranial Aneurysms.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Regulatory and Quality Considerations of Antibody-drug Conjugates.
AAPS PharmSciTech·2026
HDAC inhibition via suberoylanilide hydroxamic acid ameliorates doxorubicin-induced cardiotoxicity.
Nature communications·2026